<?xml version="1.0" encoding="UTF-8"?>
<p>Colorectal cancer is the second cause of cancer-related death in the United States. Globally, colorectal cancer is the third leading cause of death in both men and females. According to the GLOBOCAN report of 2018, colorectal cancer is the fourth common diagnosed type of cancer [
 <xref rid="B80-molecules-25-04435" ref-type="bibr">80</xref>]. The increasing incidence rate of colorectal cancer in developed countries can be related to risk factors such as dietary, smoking, obesity, and age [
 <xref rid="B81-molecules-25-04435" ref-type="bibr">81</xref>]. Surgery remains the primary treatment modality if early diagnosed [
 <xref rid="B82-molecules-25-04435" ref-type="bibr">82</xref>]. The introduction of plant-derived phytochemicals plays an important role in the treatment and management of colorectal cancer. Phytochemicals of natural origin inhibit colorectal tumor growth through pathways such as phosphoinositide 3-kinase (PI3 kinase), STAT 3, and Wnt signaling pathway [
 <xref rid="B10-molecules-25-04435" ref-type="bibr">10</xref>].
</p>
